121 related articles for article (PubMed ID: 38606514)
1. [Retracted] Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non‑coding RNA MALAT1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606514
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] Effect of RhoC on the epithelial‑mesenchymal transition process induced by TGF‑β1 in lung adenocarcinoma cells.
Lu X; Guo H; Chen X; Xiao J; Zou Y; Wang W; Chen Q
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240098
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] MicroRNA‑329‑3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
Li W; Liang J; Zhang Z; Lou H; Zhao L; Xu Y; Ou R
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38695244
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.
Li S; Wang H; Ma R; Wang L
Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940344
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] MicroRNA‑362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
Shi C; Zhang Z
Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38334137
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis.
Chi J; Liu S; Wu Z; Shi Y; Shi C; Zhang T; Xiong B; Zeng Y; Dong X
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38038159
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] MicroRNA‑152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma.
Li Y; Min D; Wang K; Yin S; Zheng H; Liu L
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799166
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4.
Zhu Y; Shao S; Pan H; Cheng Z; Rui X
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37144481
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152
Teng Z; Xu S; Lei Q
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38488021
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] MicroRNA‑675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin.
Liu K; Jin J; Rong K; Zhuo L; Li P
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36999591
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells.
Hong B; Zhang J; Yang W
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38334182
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] MicroRNA‑1297 inhibits metastasis and epithelial‑mesenchymal transition by targeting AEG‑1 in cervical cancer.
Wang Z; He S; Guo P; Guo X; Zheng J
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856442
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] MicroRNA‑383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.
Yan F; Tu Z; Duan L; Wang D; Lin F
Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37477138
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109991
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080647
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841439
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] MicroRNA‑140 represses glioma growth and metastasis by directly targeting ADAM9.
Liu X; Wang S; Yuan A; Yuan X; Liu B
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456498
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.
Shi J; Guo B; Hui Q; Chang P; Tao K
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
